Zacks: Innophos Holdings, Inc. (IPHS) Given Consensus Rating of “Strong Buy” by Analysts

Shares of Innophos Holdings, Inc. (NASDAQ:IPHS) have been given a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating. Innophos’ rating score has improved by 50% from 90 days ago as a result of a number of analysts’ upgrades and downgrades.

Zacks has also given Innophos an industry rank of 76 out of 265 based on the ratings given to its competitors.

IPHS has been the subject of a number of research reports. KeyCorp reissued a “hold” rating on shares of Innophos in a research note on Wednesday, November 1st. BidaskClub downgraded shares of Innophos from a “hold” rating to a “sell” rating in a research note on Tuesday, December 5th. Finally, Zacks Investment Research downgraded shares of Innophos from a “buy” rating to a “hold” rating in a research note on Thursday, December 14th.

Hedge funds have recently added to or reduced their stakes in the stock. Old Mutual Global Investors UK Ltd. bought a new position in shares of Innophos during the third quarter valued at approximately $109,000. Public Employees Retirement System of Ohio increased its stake in shares of Innophos by 5.9% during the second quarter. Public Employees Retirement System of Ohio now owns 2,824 shares of the specialty chemicals company’s stock valued at $124,000 after purchasing an additional 157 shares in the last quarter. Macquarie Group Ltd. bought a new position in shares of Innophos during the third quarter valued at approximately $193,000. Piedmont Investment Advisors LLC bought a new position in shares of Innophos during the third quarter valued at approximately $209,000. Finally, Alps Advisors Inc. bought a new position in shares of Innophos during the fourth quarter valued at approximately $213,000. 94.71% of the stock is owned by institutional investors.

Innophos (NASDAQ:IPHS) opened at $42.83 on Wednesday. Innophos has a one year low of $41.66 and a one year high of $58.22. The stock has a market cap of $836.43, a PE ratio of 19.65 and a beta of 0.76. The company has a quick ratio of 1.49, a current ratio of 2.86 and a debt-to-equity ratio of 0.83.

WARNING: “Zacks: Innophos Holdings, Inc. (IPHS) Given Consensus Rating of “Strong Buy” by Analysts” was reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/02/07/zacks-innophos-holdings-inc-iphs-given-consensus-rating-of-strong-buy-by-analysts.html.

Innophos Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Get a free copy of the Zacks research report on Innophos (IPHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply